A Study of IMMH-010 in Patients With Advanced Malignant Solid Tumors

Clinical trial NCT04343859 · UNKNOWN

Trial details

NCT number: NCT04343859
Sponsor: Tianjin Chasesun Pharmaceutical Co., LTD
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Malignant Neoplasms

Start date: 2020-05-14
Primary completion: 2024-12-01
Enrollment: 96

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.